Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis

Pancreas. 2005 Jan;30(1):83-6.

Abstract

Autoimmune chronic pancreatitis (AICP) is a clinically attractive entity because of its dramatic response to steroid therapy. Reported cases of AICP until now have focused on mainly clinical, radiologic, and laboratory features with steroid therapy. There are, however, few reports that demonstrate histologic recovery, especially regression of pancreatic fibrosis in patients with AICP. Fibrosis in chronic pancreatitis is generally believed to be irreversible. Our observation of reversibility of pancreatic fibrosis is, therefore, noteworthy. We illustrate this with 2 cases of AICP in which pancreatic fibrosis as well as inflammatory infiltration regressed after a short course of oral steroid therapy.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / pathology*
  • Fibrosis
  • Humans
  • Male
  • Middle Aged
  • Pancreas / pathology
  • Pancreatitis, Chronic / drug therapy*
  • Pancreatitis, Chronic / immunology
  • Pancreatitis, Chronic / pathology*
  • Prednisolone / administration & dosage*

Substances

  • Anti-Inflammatory Agents
  • Prednisolone